[1] 徐列明,刘平,沈锡中,等.肝纤维化中西医结合诊疗指南(2019年版)[J].临床肝胆病杂志,2019,35(7):1444-1449.
[2] Zimmermann HW, Tacke F.In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications[J].Expert Rev Gastroenterol Hepatol,2015,9:1139-1141.
[3] Zhang Y, Li Y, Zhang L, et al. Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis[J].Stem Cell Res Ther,2018,9(1):59.
[4] Duman DG, Zibandeh N, Ugurlu MU, et al. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model[J].Mol Biol Rep,2019,46(3):2997-3008.
[5] 范灵芝,王晓忠. 中医药抗肝纤维化治疗最新研究进展[J].新疆中医药,2018,36(1):147-151.
[6] Matsuda M,Seki E.Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogensis[J].Semin Liver Dis,2020,40(3):307-320.
[7] Mallata.Lotersztajn S.Cellular mechanisms of tissue fibrosis Novel insights into liver fibrosis[J].Am J Physiol Cell Physiol,2013,305(8):789-799.
[8] Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets[J].Hepatobiliary Pancreat Dis Int,2018,17(3):192-197.
[9] Ramachand R Anp,Hende R Sonnc.Antifibrotics inchronic liver disease:tractable targets and translational challenges[J].Lancet Gastroenterol Hepatol,2016,1(4):328-340.
[10]Papatheeodo Ridisgg V,Dalekosgg,Yu Rdaydincc,et al.Predictiona and need forssurveil lanceo of hepato cellular carcinoma(HCC) development after the first 55 years of e entecavir(ETV)or ten of ovir disoproxil fumarate therapy in caucasian chronic hepatitis B(CHB) patient sooft the PAGE-Bccohort[J].Hepatology,2018,68:11a-112a.
[11]Zavadil J,Botinger EP.TGF-β and epithelial-to-mesenehymal transitions[J] .Oncogene,2005,24(37):5764-74
[12]Swiderska-SynM,Syn WK,Xie G,et al. Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy[J].Gut,2014,63(8):1333-44.
[13]李瀚旻.从调控肝再生探讨肝纤维化的防治[J].临床肝胆病杂志,2015,31(6):992-994.
[14]李瀚旻.上皮-间质转型/间质-上皮转型失衡与髓失生肝[J].中西医结合肝病杂志,2012,22(1):1-4.
[15]Nasir GA,Mohsin S,Khan M,et al. Mesenchy-mal stem cells and interleukin-6 attenuate liver fibrosis in mice[J].J Transl Med,2013,11:78-82.
[16]Zhang CY, Yuan WG, He P, et al. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targe-ts[J].World J Gastroenterol, 2016, 22(48): 10512-10522.
[17]Feng Y, Li Y, Xu M, et al.Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis[J].Stem Cell Res Ther.2022,13(375):1-14.
[18]Qiao H,Zhou Y,Qin X,et al.NADPH oxidase signalling pathway mediates mesenchymal stem cell-induced inhibition of hepatic stellate cell activation[J].Stem Cells Int,2018:1239143.
[19]Khalfa YH,Mourad GM,Stephanos WM,et al.Bone marrow-derived mesenchymal stem cell potential regression of dysplasia associating experimental liver fibrosis in albinorats[J].Biomed Res Int,2019:5376165.
[20]Luo XY,Meng XJ,Cao DC,et al.Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes[J].Stem Cell Res Ther,2019,10(1):16.
[21]Chen X,Gan Y,Li W,et al.The interaction between mesen chymal stem cells and steroids during inflammation[J].Cell Death Dis,2014,5:e1009.
[22]Ahn YJ,Yun W,Choi JS,et al.Biodistribution of polyclustered superpara magnetic iron oxide nanoparticle labeledemsenchymal stem cells in aminoglycoside induced ototoxic mouse model[J].Biomed Eng Lett,2021,11(1):39-53.
[23]Tsuchiya A,Takeuchi S,Watanabe T,et al. Mesenchy mal stem cell therapies for liver eirrhosis:MSCs as “condecting cells”for improvement of liver fibrosis and regeneration[J].Inflamm Regen,2019,39:18.
[24]Xu L,Gong Y,Wang B,et al. Randomized trial of autolo gous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis:regulation of Treg/Th 17 cells[J].J Gastroenterol Hepatol,2014,29(8):1620-1628.
[25]Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure:a randomized controlledtrial[J].Hepatology,2017,66(1):209-219.
[26]李汶航,张睿,崔欣怡,等.一贯煎联合骨髓间充质干细胞调控 RhoA/ROCK1通路抑制大鼠肝纤维化的实验研究[J].世界中医药,2022,17(18):2563-2568.
[27]Fu X,Liu G,Halim A,et al. Mesenchymal stem cell migration and tissue repair[J].Cells,2019.8(8):784.
[28]李瀚旻. 肝主生发的理论创新及其诊疗体系的构建与应用[J].中华中医药学刊, 2023,42(6):1-5.
[29]李瑶,周昕,谢瑞芳.地五养肝胶囊治疗肝病的理论依据[J].河南中医,2018,38(2) : 257-261.
[30]Li H, Ye Z, Gao X, et al. Diwu Yanggan capsule improving liver histological response for patients with HBeAg-negative chronic hepatitis B: a randomized controlled clinical trial[J].Am J Transl Res,2018,10(5):1511-1521.
[31]宋红丽,李瀚旻,林立生,等.地五养肝胶囊对肝肾精虚大鼠肝再生的影响[J].中西医结合肝病杂志,2013,23(2) : 90-92.
[32]程思思,沈昕,彭瑜,等.地五养肝胶囊对肝纤维化大鼠肝组织EMT/MET的影响[J].时珍国医国药,2015,26(4):826-829.
[33]沈昕,程思思,彭瑜,等.地五养肝胶囊对MSG-大鼠-肝再生模型再生修复的影响及机制研究[J].中西医结合肝病杂志, 2023, 33(8):705-709.